Todd M. Hansen
33Patents
9h-index
104Co-inventors
78Inventor score
Filing activity: Mar 12, 2003 → Oct 7, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8546399B2 | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases | Emerging Cross-Sectional Technologies | 57 | Active |
| US8586754B2 | BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | Chemistry; Metallurgy | 55 | Active |
| US8557983B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 40 | Active |
| US8580794B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 35 | Active |
| US8816095B2 | Na channels, disease, and related assays and compositions | Chemistry; Metallurgy | 32 | Active |
| US9029404B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 16 | Active |
| US9034875B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 16 | Active |
| US7119205B2 | Thienopyridones as AMPK activators for the treatment of diabetes and obesity | Chemistry; Metallurgy | 15 | Expired |
| US9174982B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Emerging Cross-Sectional Technologies | 15 | Active |
| US9073855B2 | BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases | Chemistry; Metallurgy | 9 | Active |
| US9045420B2 | Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | Chemistry; Metallurgy | 9 | Active |
| US8940737B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 7 | Active |
| US8748627B2 | Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome | Chemistry; Metallurgy | 6 | Active |
| US8975398B2 | NAMPT inhibitors | Chemistry; Metallurgy | 4 | Active |
| US8889675B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 3 | Active |
| US9302989B2 | NAMPT and rock inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9227963B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 2 | Active |
| US9266877B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 2 | Active |
| US9187472B2 | NAMPT inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9877958B2 | Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 1 | Active |
| US9844547B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 1 | Active |
| US9994581B2 | Bromodomain inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9758511B2 | NAMPT inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11786519B2 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US8163769B2 | Antibacterial compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.